ヘリオス (Healios) とアサーシス (Athersys)、マルチステム (MultiStem®) 療法を使った 脳卒中治療において再生医療のパートナーシップを結ぶ
12 janv. 2016 15h16 HE
|
Athersys, Inc.
米国クリーブランド、東京, Jan. 13, 2016 (GLOBE NEWSWIRE) -- 株式会社ヘリオス (Healios K.K.、以下「ヘリオス」、東京株式取引所4593) とアサーシス社 (Athersys, Inc.、以下「アサーシス」) (NASDAQ:ATHX) は、虚血性脳卒中及びその他の適応症の治療のために、日本においてマルチステム (MultiStem®)...
Healios and Athersys Enter Into Regenerative Medicine Partnership for Treatment of Stroke Using MultiStem® Therapy
08 janv. 2016 06h00 HE
|
Athersys, Inc.
CLEVELAND and TOKYO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Healios K.K. (“Healios”) (Tokyo Stock Exchange: 4593) and Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) have announced a partnership and license...
Healios and Athersys Enter Into Regenerative Medicine Partnership for Treatment of Stroke Using MultiStem® Therapy
08 janv. 2016 03h00 HE
|
Athersys, Inc.
CLEVELAND and TOKYO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Healios K.K. (“Healios”) (Tokyo Stock Exchange:4593) and Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) have announced a partnership and license...
Athersys to Present at Biotech Showcase(TM) 2016
04 janv. 2016 13h30 HE
|
Athersys, Inc.
CLEVELAND, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and Chief Executive Officer, will present at the Biotech ShowcaseTM 2016...
Athersys’ MultiStem® Promotes Recovery After Acute Spinal Cord Injury in Preclinical Study
19 nov. 2015 05h36 HE
|
Athersys, Inc.
Peer-Reviewed Study in Nature’s Scientific Reports Demonstrates Stem Cell Therapy Promotes Improved Walking and Urinary Function CLEVELAND, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Athersys,...
Athersys Reports Third Quarter 2015 Results
05 nov. 2015 16h03 HE
|
Athersys, Inc.
CLEVELAND, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial results for the three months ended September 30, 2015. Highlights of the third quarter of...
Athersys Updates on Development Strategy in Japan
21 oct. 2015 06h30 HE
|
Athersys, Inc.
CLEVELAND, Oct. 21, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) announced today that Athersys and Chugai Pharmaceutical Co., Ltd. (“Chugai”) have ended the license...
Athersys to Host Third Quarter Financial Results Call
12 oct. 2015 15h00 HE
|
Athersys, Inc.
CLEVELAND, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2015 financial results at approximately 4:00 PM EST on Thursday, November 5, 2015, and...
Athersys to Present at 2015 Stem Cell Meeting on the Mesa
02 oct. 2015 10h30 HE
|
Athersys, Inc.
CLEVELAND, Oct. 02, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the annual Partnering Forum, part of the Stem...
Athersys Reports Second Quarter 2015 Results
06 août 2015 16h05 HE
|
Athersys, Inc.
CLEVELAND, Aug. 06, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial and operating results for the three months ended June 30, 2015. Highlights of the second...